An Autoantibody Against Human DNA-topoiomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer

Annals of Thoracic Surgery- Netherlands

doi 10.1016/j.athoracsur.2018.01.036

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Hsa_circ_0033155: A Potential Novel Biomarker for Non‑small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Mitochondrial‑DNA‑associated TLR9 Signalling Is a Potential Serological Biomarker for Non‑small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Clarification Needed Regarding Anti-Topoisomerase I as a Biomarker for Non-Small Cell Lung Cancer

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

MicroRNAs: A Novel Potential Biomarker for Diagnosis and Therapy in Patients With Non-Small Cell Lung Cancer

Cell Proliferation
MedicineCell Biology
2017English

Alpha-Actinin 4 Is Associated With Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

CPSF3 Is a Promising Prognostic Biomarker and Predicts Recurrence of Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer

PLoS ONE
Multidisciplinary
2009English

Use of Cell Free DNA as a Prognostic Biomarker in Non-Small Cell Lung Cancer Patients With Bone Metastasis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy